SCHEMBL6830991

SCHEMBL6830991

Cc1ccc(C(=O)Nc2cc[c]nc2)c(N2CCC(C)CC2)n1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 4/20 0.48
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
GAA P10253 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KIF18A Q8NI77 7/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
OPRK1 P41145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6825969 0.86 SCN10A (0.52) SCN10AALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL6643128 0.77 ALDH1A1 (0.53) SCN10AALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL6826031 0.77 SCN10A (0.47) SCN10AALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL6645120 0.76 ALDH1A1 (0.53) SCN10AALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL6647449 0.76 PDE7A (0.47) SCN10AALDH1A1MAPTSMN1; SMN2KDM4E
SCHEMBL6829403 0.76 SCN10A (0.63) SCN10AALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL6646172 0.74 KMT2A (0.63) ALDH1A1MAPTSMN1; SMN2GAANPC1
SCHEMBL6830989 0.74 SCN10A (0.42) SCN10AALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL6825968 0.73 SCN10A (0.41) SCN10AALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL6646082 0.73 SCN10A (0.46) SCN10AALDH1A1MAPTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004039795-A2 AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-13 WO disclosed